We have located links that may give you full text access.
Tumor Specific Hybrid nanoparticles in therapy of breast cancer.
Journal of Microencapsulation 2023 December 15
AIM: In this study, salicylic acid dopped into poly(3-hydroxybutyrate) and prepared nanoparticles (NPs) to increase encapsulation efficiency, anti-cancer activity of caffeic acid (Caff) and folic acid (FA) for breast cancer treatment.
METHOD: NPs were prepared by solvent evaporation method and characterized by FTIR, DSC, SEM, entrapment-loading efficiencies. The mean diameter, polydispersity index and zeta potential (ZP) were evaluated by DLS. In vitro release and stability studies were done via eppendorf method. The cytotoxicity, cell dead and internalization of NPs were shown by MTT, fluorescein and confocal microscopy.
RESULTS: The diameter and ZP of NPs were 172 ± 7 nm and -29 ± 0.38 mV. The entrapment efficiencies of 5 and 10 Caff NPs were 79 ± 0.23% and 70 ± 0.42%. NPs showed good stability within 30 days and sustained release over 25 days. FA-5Caff NPs showed 37 ± 0.3% viability on MCF-7.
CONCLUSION: FA-Caff NPs were identified as promising carrier system for breast cancer therapy.
METHOD: NPs were prepared by solvent evaporation method and characterized by FTIR, DSC, SEM, entrapment-loading efficiencies. The mean diameter, polydispersity index and zeta potential (ZP) were evaluated by DLS. In vitro release and stability studies were done via eppendorf method. The cytotoxicity, cell dead and internalization of NPs were shown by MTT, fluorescein and confocal microscopy.
RESULTS: The diameter and ZP of NPs were 172 ± 7 nm and -29 ± 0.38 mV. The entrapment efficiencies of 5 and 10 Caff NPs were 79 ± 0.23% and 70 ± 0.42%. NPs showed good stability within 30 days and sustained release over 25 days. FA-5Caff NPs showed 37 ± 0.3% viability on MCF-7.
CONCLUSION: FA-Caff NPs were identified as promising carrier system for breast cancer therapy.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app